Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clarification of the published survival analysis in H3F3B p.K27I-mutant diffuse midline glioma.

Acta neuropathologica communications·2026
Same author

Patient Utilization and Satisfaction of Supportive Skin Care Products Among Children with Cancer Receiving Mitogen-Activated Protein Kinase Pathway Inhibitors.

Journal of pediatric hematology/oncology nursing·2026
Same author

Systemic immune-inflammation and response indices is associated with early but not long-term survival after primary stereotactic radiosurgery for brain metastases.

British journal of neurosurgery·2026
Same author

Translating transcriptomics analysis into diagnostic workflows: clinical variant identification and interpretation in hypothesis-driven and hypothesis-free approaches.

EBioMedicine·2026
Same author

TANC1::HTRA1 and KPNA4::WWTR1 fusions in non-vestibular intracranial schwannomas.

Acta neuropathologica·2026
Same author

Imaging diagnosis of adult-type diffuse gliomas in the era of WHO CNS5 and cIMPACT-NOW updates 8-11: a narrative review.

Japanese journal of radiology·2026

Related Experiment Video

Updated: Jan 12, 2026

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
08:02

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

16.9K

Germinoma: Presentation, Management, and Recent Advances.

Anthony Pak-Yin Liu1, Hirokazu Takami2, Mohamed S Abdelbaki3

  • 1Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Advances in Cancer Research
|November 6, 2025
PubMed
Summary
This summary is machine-generated.

Central Nervous System (CNS) germinomas are rare brain tumors in young people. Highly treatable with radiation and chemotherapy, they represent one of the most curable intracranial cancers.

Keywords:
Clinical trialGerminomaKITLiquid biopsyPersonalized medicine

More Related Videos

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.6K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.1K

Related Experiment Videos

Last Updated: Jan 12, 2026

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
08:02

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

16.9K
Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.6K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.1K

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Oncology

Background:

  • Central Nervous System (CNS) germinomas are rare malignant germ cell tumors.
  • These tumors primarily affect children, adolescents, and young adults (AYA).
  • CNS germinomas exhibit high sensitivity to chemotherapy and irradiation.

Purpose of the Study:

  • To provide a comprehensive review of CNS germinomas.
  • To cover epidemiology, pathogenesis, clinical presentation, diagnostics, and treatment.
  • To discuss molecular advances and future therapeutic implications.

Main Methods:

  • Literature review of germinoma epidemiology, pathogenesis, and clinical aspects.
  • Analysis of current diagnostic and treatment strategies.
  • Review of recent molecular biology findings and future directions.

Main Results:

  • CNS germinomas are among the most curable intracranial malignancies.
  • Current treatments involve irradiation and chemotherapy.
  • Molecular biology insights are paving the way for novel therapeutic developments.

Conclusions:

  • CNS germinomas, while rare, are highly curable brain tumors in AYA.
  • A comprehensive understanding of germinoma is crucial for effective management.
  • Future research in molecular biology holds promise for improved therapeutic strategies.